Literature DB >> 27111497

Relationship between Serum Albumin Level and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Saphenous Vein Graft Disease in Coronary Bypass.

Mehmet Kadri Akboga1, Cagri Yayla1, Kevser Gulcihan Balci1, Ozcan Ozeke1, Orhan Maden1, Halil Kisacik1, Ahmet Temizhan1, Sinan Aydogdu1.   

Abstract

Background Previous studies proposed that inflammation, oxidative stress, and impaired endothelial dysfunction have a crucial role in occurrence of saphenous vein graft (SVG) disease (SVGD). The aim of this study was to assess the relationship between monocyte-to-high-density lipoprotein cholesterol (HDL-C) ratio (MHR) and serum albumin (SA) level as readily available inflammatory and oxidative stress markers with the presence of SVGD in patients with a coronary bypass. Methods In this retrospective cross-sectional study, a total of 257 patients (n = 112 SVGD [+] [mean age was 65.3 ± 8.4 years, 75.0% males] and n = 145 SVGD [-] [mean age was 66.5 ± 10.1 years, 74.5% males]) were enrolled. At least one SVG with ≥ 50% stenosis was defined as SVGD. Independent predictors of SVGD were determined by logistic regression analysis. Results White blood cell, neutrophil, monocyte, the age of SVG, and MHR were significantly higher, whereas SA level was significantly lower in patients with SVGD. In regression analysis, neutrophil, age of SVG, SA (odds ratio [OR]: 0.232 [0.156-0.370], p < 0.001), and MHR (OR: 1.122 [1.072-1.174], p < 0.001) remained as independent predictors of SVGD. Moreover, age of SVG showed a significant negative correlation with SA (r = - 0.343, p < 0.001) and a positive correlation with MHR (r = 0.238, p < 0.001). In the receiver-operating characteristic curve analysis, the cutoff value of ≤ 3.75 g/dL for SA has a 73.2% sensitivity and 64.8% specificity and the cutoff value of ≥ 12.1 for MHR has a 71.4% sensitivity and 60.0% specificity for prediction of SVGD. Conclusion Consequently, to the best of our knowledge, this is the first study showing a significant and independent association between SA and MHR with SVGD. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27111497     DOI: 10.1055/s-0036-1582260

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  7 in total

1.  Inflammatory Conditions in Acute Coronary Syndrome Patients Treated with Percutaneous Coronary Intervention of Saphenous Vein Graft.

Authors:  Tayyar Cankurt; İbrahim E Celik; Selcuk Ozturk; Orhan Maden
Journal:  Int J Angiol       Date:  2020-08-30

2.  Oxidative stress and Syntax score.

Authors:  Selami Soylemez
Journal:  Herz       Date:  2016-12-15       Impact factor: 1.443

Review 3.  Review of risk factors, treatment, and prevention of saphenous vein graft disease after coronary artery bypass grafting.

Authors:  Jing Gao; Yin Liu; Yu-Ming Li
Journal:  J Int Med Res       Date:  2018-09-04       Impact factor: 1.671

4.  Assessment of the Relationship between Monocyte to High-Density Lipoprotein Ratio and Myocardial Bridge.

Authors:  Asim Enhos; Kahraman Cosansu; Mustafa Ahmet Huyut; Fahrettin Turna; Erdem Karacop; Nijad Bakshaliyev; Aydin Nadir; Ramazan Ozdemir; Mahmut Uluganyan
Journal:  Arq Bras Cardiol       Date:  2018-12-17       Impact factor: 2.000

5.  Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention.

Authors:  Ting-Ting Wu; Ying-Ying Zheng; You Chen; Zi-Xiang Yu; Yi-Tong Ma; Xiang Xie
Journal:  Lipids Health Dis       Date:  2019-10-22       Impact factor: 3.876

6.  Relationship between C-reactive protein to albumin ratio and Coronary Artery Calcium Score and CAD-RADS scores with Coronary Computed Tomography Angiography.

Authors:  Mehmet Akif Erdöl; Kadriye Gayretli Yayla
Journal:  Turk J Med Sci       Date:  2021-08-27       Impact factor: 0.973

7.  A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.

Authors:  Fatih Mehmet Ucar
Journal:  BMC Cardiovasc Disord       Date:  2016-10-03       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.